Questions discussed in this category
For instance, what do you do when patients have chronic tremors, cognitive impairment, hypertension, etc.?
Is there an absolute cutoff for AST/ALT that you use where the risks outweigh the potential harm reduction benefits of using the medication? &nbs...
I have several forensic patients who have elevated LFTs and fatty liver on ultrasound, at least in part due to long-term olanzapine use. They are all ...
257921986024935237052414920827
Papers discussed in this category
Frontiers in psychiatry, 2018 Oct 08
Pharmacoepidemiology and drug safety, 2018 Sep 25
The Journal of clinical psychiatry, 2020 Aug 04
Drug and alcohol dependence, 2024 Sep 07
JAMA psychiatry, 2025 Apr 01
The New England journal of medicine, 2024 Jul 25
JHEP reports : innovation in hepatology, 2024 Apr 10